# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821586-24-000025
Filing Date
2024-08-07
Accepted
2024-08-07 08:04:51
Documents
85
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mnlk-20240630.htm iXBRL | 10-Q | 1111344
2 | EX-31.1 | mltx_2024q2xex311dasilva.htm | EX-31.1 | 10304
3 | EX-31.2 | mltx_2024q2xex312bodenstedt.htm | EX-31.2 | 10216
4 | EX-32.1 | mltx_2024q2xex321dasilva.htm | EX-32.1 | 4948
5 | EX-32.2 | mltx_2024q2xex322bodenstedt.htm | EX-32.2 | 4885
| Complete submission text file | 0001821586-24-000025.txt |  | 6631941

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mnlk-20240630.xsd | EX-101.SCH | 45928
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mnlk-20240630_cal.xml | EX-101.CAL | 69139
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mnlk-20240630_def.xml | EX-101.DEF | 277166
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mnlk-20240630_lab.xml | EX-101.LAB | 579939
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mnlk-20240630_pre.xml | EX-101.PRE | 451806
88 | EXTRACTED XBRL INSTANCE DOCUMENT | mnlk-20240630_htm.xml | XML | 782388

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39630 | Film No.: 241181520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)